Table 5.

a: Higher parenchyma moments: Controls Baseline vs. Post-furosemide
Shape	Baseline	Post-Furosemide	P-value †	d ‡
μ1	23.8 ± 2.7	20.6 ± 4.1	0.008	0.84
μ2	88.7 ± 39	48.5 ± 15	0.001	1.04
μ3	1.26 ± 0.8 × 103	0.59 ± 0.3 × 103	0.007	0.83
μ4	53 ± 43 × 103	22 ± 14 × 103	0.007	0.72

b: Higher parenchyma moments: CKD Baseline vs. Post-furosemide
Shape	Baseline	Post-Furosemide	P-value †	d ‡
μ1	26.3 ± 6.1	24.8 ± 5.6	0.02	0.21
μ2	79.3 ± 26	73.6 ± 30	0.28	0.17
μ3	0.87 ± 0.53 × 103	0.89 ± 0.65 × 103	0.56	−0.02
μ4	36.5 ± 22 × 103	36.8 ± 30 × 103	0.88	−0.01

^†Wilcoxon signed rank test statistic

^‡Cohen’s d measure of effect size